Showing results (531-540 of 654) with videos related to
Sort By:
Pageof 66
The Lancet. Planetary Health|April 5, 2024
Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trialZhiyan Zhang, Hiddo J L Heerspink, Glenn M Chertow, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 2, 2009
Development and validation of GFR-estimating equations using diabetes, transplant and weightLesley A Stevens, Christopher H Schmid, Yaping L Zhang, et al.Clinical Kidney Journal|March 3, 2023
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney diseaseRajiv Agarwal, Bertram Pitt, Biff F Palmer, et al.NEJM Evidence|February 6, 2024
Dapagliflozin and Anemia in Patients with Chronic Kidney DiseaseAkihiko Koshino, Meir Schechter, Glenn M Chertow, et al.The New England Journal of Medicine|September 24, 2020
Dapagliflozin in Patients with Chronic Kidney DiseaseHiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, et al.Kidney International|September 24, 2021
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney functionHiddo J L Heerspink, David Cherney, Douwe Postmus, et al.Kidney Medicine|September 25, 2023
Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY AnalysisSylvia E Rosas, Luis M Ruilope, Stefan D Anker, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 18, 2026
Kidney and Survival Outcomes with Semaglutide by Chronic Kidney Disease Severity in the FLOW TrialKatherine R Tuttle, Johannes F E Mann, Manuel M Mayrdorfer, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2016
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysisJustyna Siwy, Petra Zürbig, Angel Argiles, et al.Journal of the American College of Cardiology|September 1, 2024
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW TrialRichard E Pratley, Katherine R Tuttle, Peter Rossing, et al.Pageof 66